mlsanityData to 7 Oct 2026

MIMOSA: Multi-constraint Molecule Sampling for Molecule Optimization

arXiv 2010.02318 ↗First posted 5 Oct 2020cs.LG cs.AIcited by 48

Not on the map. Why?

Abstract (arXiv)

Molecule optimization is a fundamental task for accelerating drug discovery, with the goal of generating new valid molecules that maximize multiple drug properties while maintaining similarity to the input molecule. Existing generative models and reinforcement learning approaches made initial success, but still face difficulties in simultaneously optimizing multiple drug properties. To address such challenges, we propose the MultI-constraint MOlecule SAmpling (MIMOSA) approach, a sampling framework to use input molecule as an initial guess and sample molecules from the target distribution. MIMOSA first pretrains two property agnostic graph neural networks (GNNs) for molecule topology and substructure-type prediction, where a substructure can be either atom or single ring. For each iteration, MIMOSA uses the GNNs' prediction and employs three basic substructure operations (add, replace, delete) to generate new molecules and associated weights. The weights can encode multiple constraints including similarity and drug property constraints, upon which we select promising molecules for next iteration. MIMOSA enables flexible encoding of multiple property- and similarity-constraints and can efficiently generate new molecules that satisfy various property constraints and achieved up to 49.6% relative improvement over the best baseline in terms of success rate. The code repository (including readme file, data preprocessing and model construction, evaluation) is available https://github.com/futianfan/MIMOSA.

Key facts. Cited by 48 papers in the map (data through 7 Oct 2026). First posted on arXiv 5 Oct 2020.

Builds on

No reference list yet.

Built on by

Cited by year (2026 to 7 Oct)

Citing papers per year: 2021: 4; 2022: 14; 2023: 9; 2024: 9; 2025: 8; 2026: 4.

48 papers.

Sort:

By area:

  1. 2022ADBench: Anomaly Detection Benchmarkcited by 230
  2. 2022ECOD: Unsupervised Outlier Detection Using Empirical Cumulative Distribution Functionscited by 153
  3. 2023Machine Learning for Synthetic Data Generation: A Reviewcited by 118
  4. 2022Accelerating Bayesian Optimization for Biological Sequence Design with Denoising Autoencoderscited by 99
  5. 2022MolGenSurvey: A Systematic Survey in Machine Learning Models for Molecule Designcited by 66
  6. 2021Differentiable Scaffolding Tree for Molecular Optimizationcited by 53
  7. 2021HINT: Hierarchical Interaction Network for Trial Outcome Prediction Leveraging Web Datacited by 49
  8. 2022Reinforced Genetic Algorithm for Structure-based Drug Designcited by 46
  9. 2022PyGOD: A Python Library for Graph Outlier Detectioncited by 31
  10. 2022Computer-Aided Multi-Objective Optimization in Small Molecule Discoverycited by 31
  11. 2023Coarse-to-Fine: a Hierarchical Diffusion Model for Molecule Generation in 3Dcited by 24
  12. 2024TWIN-GPT: Digital Twins for Clinical Trials via Large Language Modelcited by 24
36 more
  1. 2022Controllable Data Generation by Deep Learning: A Reviewcited by 20
  2. 2024Uncertainty Quantification on Clinical Trial Outcome Predictioncited by 19
  3. 2025GeLLMO: Generalizing Large Language Models for Multi-property Molecule Optimizationcited by 16
  4. 2022Interpretable Molecular Graph Generation via Monotonic Constraintscited by 15
  5. 2022Molecule Generation for Drug Design: a Graph Learning Perspectivecited by 13
  6. 2022Disentangled Spatiotemporal Graph Generative Modelscited by 12
  7. 2024Text-guided multi-property molecular optimization with a diffusion language modelcited by 11
  8. 2023Lo-Hi: Practical ML Drug Discovery Benchmarkcited by 10
  9. 2023Molecule Design by Latent Space Energy-Based Modeling and Gradual Distribution Shiftingcited by 8
  10. 2024Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?cited by 7
  11. 2024DrugCLIP: Contrastive Drug-Disease Interaction For Drug Repurposingcited by 7
  12. 2023Beam Enumeration: Probabilistic Explainability For Sample Efficient Self-conditioned Molecular Designcited by 5
  13. 2024TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasetscited by 5
  14. 2023GNN-Ensemble: Towards Random Decision Graph Neural Networkscited by 4
  15. 2025DrugImproverGPT: A Large Language Model for Drug Optimization with Fine-Tuning via Structured Policy Optimizationcited by 4
  16. 2025Gradient GA: Gradient Genetic Algorithm for Drug Molecular Designcited by 4
  17. 2023PyTrial: Machine Learning Software and Benchmark for Clinical Trial Applicationscited by 3
  18. 2023Molecular De Novo Design through Transformer-based Reinforcement Learningcited by 3
  19. 2025ScaffoldGPT: A Scaffold-based GPT Model for Drug Optimizationcited by 3
  20. 2024AUTODIFF: Autoregressive Diffusion Modeling for Structure-based Drug Designcited by 2
  21. 2025Large Language Models for Controllable Multi-property Multi-objective Molecule Optimizationcited by 2
  22. 2026Beyond Affinity: A Benchmark of 1D, 2D, and 3D Methods Reveals Critical Trade-offs in Structure-Based Drug Designcited by 2
  23. 2022Molecule optimization via multi-objective evolutionary in implicit chemical spacecited by 1
  24. 2023Will More Expressive Graph Neural Networks do Better on Generative Tasks?cited by 1
  25. 2024Structure-Based Drug Design via 3D Molecular Generative Pre-training and Samplingcited by 1
  26. 2025InversionGNN: A Dual Path Network for Multi-Property Molecular Optimizationcited by 1
  27. 2025MolEditRL: Structure-Preserving Molecular Editing via Discrete Diffusion and Reinforcement Learningcited by 1
  28. 2026MolSafeEval: A Benchmark for Uncovering Safety Risks in AI-Generated Moleculescited by 1
  29. 2021Realistic molecule optimization on a learned graph manifoldcited by 0
  30. 2021Approximate Inference via Clusteringcited by 0
  31. 2022Splitting numerical integration for matrix completioncited by 0
  32. 2022Accelerating Stochastic Probabilistic Inferencecited by 0
  33. 2024Quantum-inspired Reinforcement Learning for Synthesizable Drug Designcited by 0
  34. 2025GraphPINE: Graph Importance Propagation for Interpretable Drug Response Predictioncited by 0
  35. 2026Amortized Molecular Optimization via Group Relative Policy Optimizationcited by 0
  36. 2026MARCO: Multi-Round Agentic Reinforcement for Conditional Molecular Optimizationcited by 0